Literature DB >> 9726704

The incidence of symptomatic venous thromboembolism after enoxaparin prophylaxis in lower extremity arthroplasty: a cohort study of 1,984 patients. Canadian Collaborative Group.

J R Leclerc1, M Gent, J Hirsh, W H Geerts, J S Ginsberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9726704     DOI： 10.1378/chest.114.2_supplement.115s

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  13 in total

1.  Increased fibrinolysis increases bleeding in orthopedic patients receiving prophylactic fondaparinux.

Authors:  Kakunoshin Yoshida; Hideo Wada; Masahiro Hasegawa; Hiroki Wakabayashi; Takeshi Matsumoto; Yuji Shimokariya; Katsura Noma; Norikazu Yamada; Atsumasa Uchida; Tsutomu Nobori; Akihiro Sudo
Journal:  Int J Hematol       Date:  2012-01-21       Impact factor: 2.490

2.  Cost-effectiveness of extended prophylaxis with fondaparinux compared with low molecular weight heparin against venous thromboembolism in patients undergoing hip fracture surgery.

Authors:  Jonas Lundkvist; David Bergqvist; Bengt Jönsson
Journal:  Eur J Health Econ       Date:  2007-01-16

3.  Monitoring for anti-Xa activity for prophylactic administration of Fondaparinux in patients with artificial joint replacement.

Authors:  Kakunoshin Yoshida; Hideo Wada; Masahiro Hasegawa; Hiroki Wakabayashi; Honami Ando; Seika Oshima; Takeshi Matsumoto; Yuji Shimokariya; Katsura Noma; Norikazu Yamada; Atsumasa Uchida; Tsutomu Nobori; Akihiro Sudo
Journal:  Int J Hematol       Date:  2011-09-22       Impact factor: 2.490

4.  The Evaluation of D-Dimer Levels for the Comparison of Fibrinogen and Fibrin Units Using Different D-Dimer Kits to Diagnose VTE.

Authors:  Masahiro Hasegawa; Hideo Wada; Toshio Yamaguchi; Hiroki Wakabayashi; Naoki Fujimoto; Takeshi Matsumoto; Kei Hasegawa; Norikazu Yamada; Masaaki Ito; Yoshiki Yamashita; Naoyuki Katayama; Kaname Nakatani; Akihiro Sudo
Journal:  Clin Appl Thromb Hemost       Date:  2017-05-08       Impact factor: 2.389

5.  Elevated soluble platelet glycoprotein VI is a useful marker for DVT in postoperative patients treated with edoxaban.

Authors:  Takumi Aota; Katsuki Naitoh; Hideo Wada; Yoshiki Yamashita; Noriki Miyamoto; Masahiro Hasegawa; Hiroki Wakabayashi; Kakunoshin Yoshida; Kunihiro Asanuma; Takeshi Matsumoto; Kohshi Ohishi; Yuji Shimokariya; Norikazu Yamada; Masakatsu Nishikawa; Naoyuki Katayama; Atsumasa Uchida; Akihiro Sudo
Journal:  Int J Hematol       Date:  2014-09-25       Impact factor: 2.490

6.  Comparison of three different anti-Xa assays in major orthopedic surgery patients treated with fondaparinux.

Authors:  Makoto Ikejiri; Hideo Wada; Toshio Yamaguchi; Shinichi Miyazaki; Masahiro Hasegawa; Hiroki Wakabayashi; Kunihiro Asanuma; Akane Sakaguchi; Takeshi Matsumoto; Kohshi Ohishi; Naoki Fujimoto; Norikazu Yamada; Masaaki Ito; Naoyuki Katayama; Akihiro Sudo
Journal:  Int J Hematol       Date:  2016-02-27       Impact factor: 2.490

7.  Venous thromboembolism after major orthopaedic surgery: a population-based cohort study.

Authors:  Davide Imberti; Cosetta Bianchi; Antonella Zambon; Andrea Parodi; Luca Merlino; Massimo Gallerani; Giovanni Corrao
Journal:  Intern Emerg Med       Date:  2011-03-26       Impact factor: 3.397

8.  Fibrin-related markers for diagnosing acute-, subclinical-, and pre-venous thromboembolism in patients with major orthopedic surgery.

Authors:  Toshio Yamaguchi; Hideo Wada; Shinichi Miyazaki; Masahiro Hasegawa; Hiroki Wakabayashi; Kunihiro Asanuma; Naoki Fujimoto; Takeshi Matsumoto; Kohshi Ohishi; Akane Sakaguchi; Norikazu Yamada; Masaaki Ito; Yoshiki Yamashita; Naoyuki Katayama; Akihiro Sudo
Journal:  Int J Hematol       Date:  2016-02-12       Impact factor: 2.490

Review 9.  Measuring the outcomes and pharmacoeconomic consequences of venous thromboembolism prophylaxis in major orthopaedic surgery.

Authors:  Sean D Sullivan; Susan R Kahn; Bruce L Davidson; Lars Borris; Patrick Bossuyt; Gary Raskob
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

10.  Aspirin: an alternative for pulmonary embolism prophylaxis after arthroplasty?

Authors:  Ibrahim J Raphael; Eric H Tischler; Ronald Huang; Richard H Rothman; William J Hozack; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2014-02       Impact factor: 4.176
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.